Multivariate analysis as a method for evaluating the pathogenicity of novel genetic MLH1 variants in patients with colorectal cancer and microsatellite instability

Duraturo,Francesca; Liccardo,Raffaella; Cavallo,Angela; De Rosa,Marina; Rossi,Giovanni  Battista; Izzo,Paola

doi:10.3892/ijmm.2015.2255

Multivariate analysis as a method for evaluating the pathogenicity of novel genetic MLH1 variants in patients with colorectal cancer and microsatellite instability

Authors:
- Francesca Duraturo
- Raffaella Liccardo
- Angela Cavallo
- Marina De Rosa
- Giovanni Battista Rossi
- Paola Izzo
View Affiliations

Affiliations: Department of Molecular Medicine and Medical Biotechnology, University of Naples ̔Federico Ⅱ̓, I‑80131 Naples, Italy, Endoscopy Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, ̔Fondazione Giovanni Pascale̓ IRCCS, I‑80131 Naples, Italy
Published online on: June 19, 2015 https://doi.org/10.3892/ijmm.2015.2255
Pages: 511-517

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Loss of function of mismatch repair (MMR) genes, mainly MLH1 and MSH2, manifests as high levels of microsatellite instability (MSI) that occurs in >90% of carcinomas in patients with Lynch syndrome (LS). The MSI‑high status has also been described in sporadic colorectal cancer (CRC) associated with BRAF gene mutation (V600E); this mutation was not present in LS‑associated cancers. The present study performed MSI analysis on 39 CRC patients selected according to Bethesda guidelines, and BRAF V600E genotyping was performed in 26 cases classified as MSI‑high or MSI‑low (15 MSI‑H and 11 MSI‑L). These 26 patients were then screened for MLH1 and MSH2 germ‑line mutations. Germ‑line mutations in these genes were detected in 11/15 patients with MSI‑H tumors (73%) and in 1/11 patients with MSI‑L tumors (9%). Overall, 11 germ‑line mutations in 12/26 analyzed patients (46%) in these genes were identified. Two of these mutations are novel genetic MLH1 variants not previously described in the literature, c.438A>G and c.1844T>C. A combination of computational approaches, co‑segregation analysis and RNA assay suggested that these novel mutations, silent and missense, respectively, were probably pathogenic. The findings of the present study further emphasized the requirement for genetic testing in patients with a risk for hereditary CRC and has broadened the spectrum of known mutations of the MLH1 gene.

View Figures

View References

1	De Rosa M, Dourisboure RJ, Morelli G, Graziano A, Gutiérrez A, Thibodeau S, Halling K, Avila KC, Duraturo F, Podesta EJ, et al: First genotype characterization of Argentinean FAP patients: Identification of 14 novel APC mutations. Hum Mutat. 23:523–524. 2004. View Article : Google Scholar : PubMed/NCBI
2	De Rosa M, Galatola M, Borriello S, Duraturo F, Masone S and Izzo P: Implication of adenomatous polyposis coli and MUTYH mutations in familial colorectal polyposis. Dis Colon Rectum. 52:268–274. 2009. View Article : Google Scholar : PubMed/NCBI
3	Lynch PM: The hMSH2 and hMLH1 genes in hereditary nonpolyposis colorectal cancer. Surg Oncol Clin N Am. 18:611–624. 2009. View Article : Google Scholar : PubMed/NCBI
4	Duraturo F, Liccardo R, Cavallo A, De Rosa M, Grosso M and Izzo P: Association of low-risk MSH3 and MSH2 variant alleles with Lynch syndrome: Probability of synergistic effects. Int J Cancer. 129:1643–1650. 2011. View Article : Google Scholar
5	Barrow E, Hill J and Evans DG: Cancer risk in Lynch Syndrome. Fam Cancer. 12:229–240. 2013. View Article : Google Scholar : PubMed/NCBI
6	Vasen HF, Watson P, Mecklin JP and Lynch HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 116:1453–1456. 1999. View Article : Google Scholar : PubMed/NCBI
7	Wolf B, Gruber S, Henglmueller S, Kappel S, Bergmann M, Wrba F and Karner-Hanusch J: Efficiency of the revised Bethesda guidelines (2003) for the detection of mutations in mismatch repair genes in Austrian HNPCC patients. Int J Cancer. 118:1465–1470. 2006. View Article : Google Scholar
8	Wang L, Cunningham JM, Winters JL, Guenther JC, French AJ, Boardman LA, Burgart LJ, McDonnell SK, Schaid DJ and Thibodeau SN: BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res. 63:5209–5212. 2003.PubMed/NCBI
9	Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espín E, Armengol M, et al: BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet. 41:664–668. 2004. View Article : Google Scholar : PubMed/NCBI
10	Ng PC and Henikoff S: SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 31:3812–3814. 2003. View Article : Google Scholar : PubMed/NCBI
11	Ramensky V, Bork P and Sunyaev S: Human non-synonymous SNPs: Server and survey. Nucleic Acids Res. 30:3894–3900. 2002. View Article : Google Scholar : PubMed/NCBI
12	Rost B, Yachdav G and Liu J: The PredictProtein server. Nucleic Acids Res. 32:W321–W326. 2004. View Article : Google Scholar : PubMed/NCBI
13	Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M and Béroud C: Human Splicing Finder: An online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 37:e672009. View Article : Google Scholar : PubMed/NCBI
14	Costabile V, Duraturo F, Delrio P, Rega D, Pace U, Liccardo R, Rossi GB, Genesio R, Nitsch L, Izzo P, et al: Lithium chloride induces mesenchymal to epithelial reverting transition in primary colon cancer cell cultures. Int J Oncol. 46:1913–1923. 2015.PubMed/NCBI
15	Woods MO, Williams P, Careen A, Edwards L, Bartlett S, McLaughlin JR and Younghusband HB: A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat. 28:669–673. 2007. View Article : Google Scholar : PubMed/NCBI
16	Genuardi M, Viel A, Bonora D, Capozzi E, Bellacosa A, Leonardi F, Valle R, Ventura A, Pedroni M, Boiocchi M, et al: Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility. Hum Genet. 102:15–20. 1998. View Article : Google Scholar : PubMed/NCBI
17	Mester JL, Moore RA and Eng C: PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: Would use of risk assessment tools reduce genetic testing? Oncologist. 18:1083–1090. 2013. View Article : Google Scholar : PubMed/NCBI
18	Galatola M, Paparo L, Duraturo F, Turano M, Rossi GB, Izzo P and De Rosa M: Beta catenin and cytokine pathway dysregulation in patients with manifestations of the ‘PTEN hamartoma tumor syndrome’. BMC MedGenet. 13:282012.
19	Paparo L, Rossi GB, Delrio P, Rega D, Duraturo F, Liccardo R, Debellis M, Izzo P and De Rosa M: Differential expression of PTEN gene correlates with phenotypic heterogeneity in three cases of patients showing clinical manifestations of PTEN hamartoma tumour syndrome. Hered Cancer Clin Pract. 11:82013. View Article : Google Scholar : PubMed/NCBI
20	Lynch HT and Lynch J: Lynch syndrome: Genetics, natural history, genetic counseling, and prevention. J Clin Oncol. 18(Suppl): 19S–31S. 2000.PubMed/NCBI
21	Galatola M, Miele E, Strisciuglio C, Paparo L, Rega D, Delrio P, Duraturo F, Martinelli M, Rossi GB, Staiano A, et al: Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis. World J Gastroenterol. 19:8659–8670. 2013. View Article : Google Scholar :
22	Duraturo F, Cavallo A, Liccardo R, Cudia B, De Rosa M, Diana G and Izzo P: Contribution of large genomic rearrangements in Italian Lynch syndrome patients: characterization of a novel alu-mediated deletion. Biomed Res Int. 2013:2198972013. View Article : Google Scholar : PubMed/NCBI
23	Rahner N, Friedrichs N, Wehner M, Steinke V, Aretz S, Friedl W, Buettner R, Mangold E, Propping P and Walldorf C: Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome. Acta Oncol. 46:763–769. 2007. View Article : Google Scholar : PubMed/NCBI
24	Lipkin SM, Wang V, Stoler DL, Anderson GR, Kirsch I, Hadley D, Lynch HT and Collins FS: Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: evidence for somatic mutation in colorectal cancers. Hum Mutat. 17:389–396. 2001. View Article : Google Scholar : PubMed/NCBI
25	Doss CG and Sethumadhavan R: Investigation on the role of nsSNPs in HNPCC genes - a bioinformatics approach. J Biomed Sci. 16:422009. View Article : Google Scholar
26	Cartegni L, Chew SL and Krainer AR: Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 3:285–298. 2002. View Article : Google Scholar : PubMed/NCBI
27	De Rosa M, Morelli G, Cesaro E, Duraturo F, Turano M, Rossi GB, Delrio P and Izzo P: Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript. Gene. 395:8–14. 2007. View Article : Google Scholar : PubMed/NCBI